UPDATED: Idera gets FDA green light for Phase II psoriasis drug test FierceBiotech The establishment sent the FDA AN initial Phase II legal proceeding protocol back in July, which would test the novel dual-TLR antagonist in psoriasis patients over xii weeks of treatment. The agency placed that programme on hold over different concerns. ... FDA clears Idera psoriasis therapy legal proceeding Pharmaceutical Business Review each 7 news articles » Link To Article
No comments:
Post a Comment